The substantiation of the role of a clinical pharmacist in preventing antibiotic resistance

I. V. Kireyev,K. V. Tsemenko,N. V. Zhabotynska,K. S. Tolmachova
DOI: https://doi.org/10.24959/sphhcj.23.304
2023-11-17
Social pharmacy in health care
Abstract:Aim. To study the role of a clinical pharmacist in overcoming antibiotic resistance in healthcare institutions that provide both primary (outpatient) and specialized (inpatient) medical care. Materials and methods. The research materials were the Order of the Ministry of Health of Ukraine No. 1513 of 23.08.2023 “The rational use of antibacterial and antifungal drugs for therapeutic and preventive purposes”. Such methods as analysis, synthesis, grouping, formal-dogmatic, logical-semantic, ascent from abstract to concrete, historical, comparative, systematic, graphic ones were used. Results. According to the results of the analysis of the new standard of medical care “The rational use of antibacterial and antifungal drugs for therapeutic and preventive purposes”, it can be noted that clinical pharmacists are responsible for promoting, managing and optimizing the use of antimicrobial drugs. It is the level of professional training, qualification and experience in working with infectious diseases that allow clinical pharmacists to be leaders of programs to combat antibiotic resistance. Conclusions. According to the provisions of the Standard, the clinical pharmacist should be in close cooperation with the doctor through counseling. An important aspect of preventing complications of antibacterial pharmacotherapy and developing antibiotic resistance is a retrospective audit of antibacterial drug prescriptions performed by a clinical pharmacist. Taking into account the above, in our opinion, it will be rational to include the elements of practical training on prospective counseling and retrospective audit of the use of antibacterial agents in the working program of “Clinical Pharmacy and Pharmaceutical Care” for applicants of higher education of the educational and professional program “Clinical Pharmacy”.
What problem does this paper attempt to address?